Scott Chesney

Motivational & Inspirational Speaker to over 1.7 million people in 44 countries.

[Eric LeGrand @EricLeGrand52]

It was awesome to be able to trial the new spinal cord stimulation technology from @onwdempowered, called ARC-EX during one of my therapy sessions.

It is a non-invasive spinal cord stimulation system that sends electrical signals through the skin to the spinal cord
#bELieve52

[ONWARD Medical @onwdempowered]

We announced our financial and operating results for the full year 2025, highlighting strong US commercial performance and major pipeline milestones.

In 2025, we established a US commercial organization that drove rapid adoption of our groundbreaking ARC-EX® System in US rehabilitation clinics. ARC-EX is the first and only FDA-cleared technology demonstrated to improve hand strength and sensation after spinal cord injury. We also achieved scientific and regulatory milestones across our technology platforms designed to deliver precise spinal cord stimulation to restore movement, function, and independence in people living with SCI and other movement disabilities.

Hear directly from CEO @onwddave Marver about our achievements.

Read the full press release: https://t.co/1nPweBIl9T

ARC-EX Indication for Use: The ARC-EX System is intended to deliver programmed, transcutaneous electrical spinal cord stimulation in conjunction with functional task practice in the clinic and with take-home exercises in the home to improve hand sensation and strength in individuals between 18 and 75 years old that present with a chronic, nonprogressive neurological deficits resulting from an incomplete spinal cord injury (C2-C8 inclusive). The ARC-EX System is intended to be operated in medical centers by rehabilitation professionals and at home by patients and persons providing assistance to patients, as needed.

Other Investigational Products: All other ONWARD Medical devices and therapies, including ARC-IM and ARC-BCI, are investigational and not available for commercial use.

[Be A King @BerniceKing]

This #MLKDay, let’s join my father in having the AUDACITY TO BELIEVE…and to be love in acting according to our belief. #MLK #MartinLutherKingJr

[Scott Chesney @scottchesney]

@Jadelume1

[ONWARD Medical @onwdempowered]

ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Study with the ARC-IM System https://t.co/8PYz6z0LLU

[ONWARD Medical @onwdempowered]

📣 We'll be there! ONWARD Medical is heading to @RehabWeekOrg 2025—one of the most influential global events in neurorehabilitation!

Join us in Chicago from May 12–16 at the Sheraton Grand Chicago Riverwalk to discover how our ARC-EX® System is helping shape the future of spinal cord injury recovery.

Stop by our tabletop exhibit in the Riverwalk AB area (Level 1) to meet our team! We'll be showcasing our ARC-EX demo, sharing exciting Up-LIFT Trial results, and discussing ONWARD's vision for #SCI recovery.

We're looking forward to connecting with you in Chicago!

To be kept informed about the Company's technologies, research studies, and the availability of therapies in your area, please complete this webform: https://t.co/7wNxGmm9RV

#RehabWeek2025 #NeuroRehabilitation #SpinalCordInjury #NeuroTech #MedicalInnovation #SCICommunity #EmpoweringMovement

ARC-EX Indication for Use (US): The ARC-EX System is intended to deliver programmed, transcutaneous electrical spinal cord stimulation in conjunction with functional task practice in the clinic to improve hand sensation and strength in individuals between 18 and 75 years old that present with a chronic, non-progressive neurological deficit resulting from an incomplete spinal cord injury (C2-C8 inclusive).

[ONWARD Medical @onwdempowered]

🔬 Exciting news! Grants from two distinguished organizations are helping advance research with our investigational ONWARD ARC-IM System to help solve the challenges of Parkinson’s disease, a condition that affects 10 million people worldwide.

Here are the highlights:

🌟 $1M from @MichaelJFoxOrg for Parkinson’s Research granted to our partner @_NeuroRestore, is funding a feasibility study to explore whether our ARC-IM System addresses mobility challenges - a critical issue affecting 90% of people with Parkinson's. The first study participant was enrolled in late 2024.

🌟 $1.5M from the US @DeptofDefense will fund a study of our ARC-IM System and blood pressure instability, which affects 800,000 people with Parkinson's in the US and Europe. This study is expected to begin in 2025.

Together, these studies could open new therapeutic possibilities for the millions of people worldwide living with Parkinson's.

To be kept informed about the Company’s technologies, research studies, and the availability of therapies in your area, please complete this webform.

https://t.co/QMOHDNsfwp

#ParkinsonsResearch #ARCIM #NeuroRestore #InnovationInHealth #MichaelJFoxFoundation #DoDGrants #MedicalBreakthroughs #ParkinsonsAwareness #HealthcareInnovation

Investigational products: The ONWARD ARC-IM System is investigational and not available for commercial use.

[ONWARD Medical @onwdempowered]

🙏 Thank you, @people, for poignantly highlighting the story of ARC-EX Therapy trial participant Jessie Owen, whose life changed in meaningful ways after the therapy. In chronicling Jessie’s journey, People Magazine shed light on the unmet needs of the spinal cord injury (SCI) community and the hope that new technologies like ARC-EX can bring to those with paralysis. ✨

As Jessie told People, this moment “gives us hope and passion.”

We appreciate People for bringing attention to this important milestone and sharing Jessie’s optimism with the world. 🌏

#EmpoweringMovement #SCI #PeopleMagazine #Hope

Note: The ARC-EX System is intended to deliver programmed, transcutaneous electrical spinal cord stimulation in conjunction with functional task practice in the clinic to improve hand sensation and strength in individuals between 18 and 75 years old that present with a chronic, non-progressive neurological deficit resulting from an incomplete spinal cord injury (C2-C8 inclusive). Please note that all other ONWARD Medical devices and therapies, including ARC-IM®, ARC-BCI®, and ARC Therapy™ with brain-computer interfaces (BCIs), are investigational and not commercially approved.  Patient testimonials reflect individual experiences and outcomes, which may vary. Please review the full product label and clinical study data.

https://t.co/XSEvHwLlWA

[ONWARD Medical @onwdempowered]

🎉 Today marks a truly historic moment – not just for our company, but for the entire spinal cord injury (SCI) community.

After more than a decade of pioneering research and unwavering dedication, we have received FDA de novo classification and authorization to market the ARC-EX® System, the world's first non-invasive spinal cord stimulation system proven to improve strength and sensation after chronic SCI. 💫

Here are some key highlights of the ARC-EX System:

⭐️ 90% of clinical trial participants showed improved strength or function* in clinical trials

⭐️ Benefits seen up to 34 years post-injury* in clinical trials

⭐️ Named a @TIME Magazine Best Invention of 2024

For the first time ever, there is an approved therapy to improve hand strength and sensation for people with SCI. This recognition is particularly meaningful because it acknowledges more than just technological innovation – it validates the benefits of this therapy for the millions of people worldwide who dream of regaining movement and independence after SCI.

We thank the entire SCI Community for supporting us in our journey to develop and introduce this breakthrough technology. Together, we are not just developing devices; we are reshaping what is possible after spinal cord injury. 🚀

🔗 For more details, read our press release (link in comments).

*Moritz, Chet, et al. “Non-invasive spinal cord stimulation for arm and hand function in chronic tetraplegia: a safety and efficacy trial.” Nature Medicine. 2024.

#EmpoweringMovement #SCI #MedicalBreakthrough #Innovation

Note: The ARC-EX System is intended to deliver programmed, transcutaneous electrical spinal cord stimulation in conjunction with functional task practice in the clinic to improve hand sensation and strength in individuals between 18 and 75 years old that present with a chronic, non-progressive neurological deficit resulting from an incomplete spinal cord injury (C2-C8 inclusive). Please note that all other ONWARD Medical devices and therapies, including ARC-IM®, ARC-BCI®, and ARC Therapy™ with brain-computer interfaces (BCIs), are investigational and not commercially approved. Patient testimonials reflect individual experiences and outcomes, which may vary. Please review the full product label and clinical study data.

[ONWARD Medical @onwdempowered]

🛎️  We just reached the “Panel Picker” phase of the SXSW submission process, and we NEED your votes to bring our proposed panel to @sxsw 's iconic gathering of innovators and creatives!

Please vote for our proposed panel, in partnership with the @ReeveFoundation, called “SCI Research: One Small Movement Can Change Lives.”

This exciting conversation will feature the Reeve Foundation’s Chief Scientific Officer, Dr. Marco Baptista, our own CEO Dave Marver, and @NeurotechNetwk and CEO Jennifer French. The discussion would be moderated by @NBCNews correspondent Ellison Barber.

Here’s how to vote for our submission:

➡️ Click on the session name: https://t.co/Jsz0ml5Qu3

➡️ If you haven’t already signed up, get a PanelPicker login (you only have to do it once)

➡️ Vote “thumbs up” for the session and comment on why you think it will be amazing!

Voting is open until August 18. Thank you for the support! 🙏

#EmpoweringMovement #SCI #SXSW #PanelPicker

[Scott Chesney @scottchesney]

Words to live by…

[ONWARD Medical @onwdempowered]

🎉 Congratulations to our research partners, @_NeuroRestore co-directors @gcourtine and @Jocelyne_Bloch, for delivering the closing plenary lecture at the #FENS2024 Forum in Vienna, Austria. The duo spoke to the enthusiastic audience at the Federation of European Neuroscience Societies (@FENSorg) conference about the therapies they have developed to address the unmet needs of people with spinal cord injury (SCI). 

The FENS Forum is Europe’s largest #neuroscience congress, covering all areas of the field, from basic to translational research, and highlighting the most up-to-date research discoveries in neuroscience. FENS represents 40 neuroscience societies and more than 20K member scientists, and conference participants gather to listen, learn, and share.

We appreciate FENS for showcasing the latest breakthroughs in neurotechnology and the work that Professor Courtine and Dr. Bloch are doing to develop innovative solutions for those with SCI.✨

*All ONWARD® Medical devices and therapies, including but not limited to ARC-IM®, ARC-EX®, ARC-BCI™, and ARC Therapy™, alone or in combination with a brain-computer interface (BCI), are investigational and not available for commercial use.

#EmpoweringMovement #SCI #Neuroscience #FENS2024

[ONWARD Medical @onwdempowered]

🎉 Today, the results from our Up-LIFT pivotal trial were published in Nature Medicine, one of the world’s preeminent scientific journals.

This @NaturePortfolio publication is a key milestone advancing our mission to address the unmet needs of the spinal cord injury (SCI) community. 📑

The Up-LIFT study was designed to evaluate the safety and effectiveness of our investigational ARC-EX® Therapy to improve upper limb mobility in people with chronic incomplete tetraplegia. The global study was conducted with 65 participants at 14 leading SCI centers in the United States, Europe, and Canada.

Here are the headlines:

⭐️ ARC-EX Therapy was shown to be safe and effective*

⭐️ 90% of participants improved either strength or function of their upper limbs*

⭐️ 87% of participants reported improvement in quality of life*

⭐️ Improvement was demonstrated in participants up to 34 years post-injury*

Study participants also reported reduced spasm frequency, improved sleep, and improved upper body sensation, including the sense of touch*. Self-care, a key component of independence after SCI, also improved statistically significantly*.

💡 These are remarkable results. Finally, there is a therapy to restore strength, function, and sensation after chronic spinal cord injury.

We have submitted an application to the US Food and Drug Administration for US regulatory clearance of the ARC-EX System. We hope to be able to offer ARC-EX Therapy to people with SCI in the US later this year and in Europe in mid-2025.

Let’s keep the momentum going. 🚀

Special thanks to Up-LIFT Clinical Trial Principal Investigators: Drs. Edelle Field-Fote, Jim Guest, Thomas Janssen, Sukhvinder Kalsi-Ryan, Andrei Krassioukov, Ralph Marino, Chet Moritz, Leslie Morse, Lynda Murray, Margaret Purcell, Candace Tefertiller, Randy Trumbower, Ilse van Nes, and Kristin Zhao.

#EmpoweringMovement #SCI #ClinicalTrials

*Moritz, Chet, et al. “Non-invasive spinal cord stimulation for arm and hand function in chronic tetraplegia: a safety and efficacy trial.” Nature Medicine. 2024.

Note: All ONWARD® Medical devices and therapies, including but not limited to ARC-IM®, ARC-EX®, ARC-BCI™, and ARC Therapy™, alone or in combination with a brain-computer interface (BCI), are investigational and not available for commercial use.

[ONWARD Medical @onwdempowered]

🛎️ We are looking forward to sharing more details about our Up-LIFT pivotal trial results, which were published in @Nature Medicine this week.

On Thursday, May 23rd at 2:30pm CET/8:30am ET following a brief Q1 Business Update, CEO Dave Marver will host a discussion of Up-LIFT pivotal trial results with a panel of principal investigators and participants. Up-LIFT demonstrated the safety and effectiveness of external ONWARD® ARC-EX® Therapy to improve hand and arm function after spinal cord injury.

Panelists will include Up-LIFT principal investigators Drs. Jim Guest, Chet Moritz, and Candy Tefertiller, ARC-EX Therapy trial participants Sherown Campbell and Jessie Owen, and Erika Ross Ellison, ONWARD Medical VP Clinical, Regulatory, and Quality.

Register in advance for the webinar here: https://t.co/zizOzejKqF

After registering, you will receive a confirmation email containing joining instructions.

#EmpoweringMovement #SCI #medtech

*All ONWARD® Medical devices and therapies, including but not limited to ARC-IM®, ARC-EX®, ARC-BCI™, and ARC Therapy™, alone or in combination with a brain-computer interface (BCI), are investigational and not available for commercial use

[ONWARD Medical @onwdempowered]

Today we shared our 2024 strategic priorities, and we have an exciting year ahead! Our top priority is commercialization, and we look forward to bringing the first-ever therapy that can improve upper limb strength and function - even years after a spinal cord injury (SCI) – to the SCI Community in the US later this year.* Here’s more detail:

➡️ ARC-EX® commercial launch. We expect to launch our investigational ARC-EX System to improve the strength and function of the upper extremities after SCI in the US in Q4 2024. Major associated milestones this year include US FDA De Novo submission, FDA clearance, and first commercial sale.

➡️ ARC-IM® pivotal study commencement. We intend to start our global pivotal study, called Empower BP, to evaluate the potential for the investigational ARC-IM System to address blood pressure instability after SCI. Major associated milestones this year include FDA investigational device exemption (IDE) submission, FDA IDE approval and first participant enrollment. 

➡️ ARC-BCI™ Therapy advancement. We plan to advance clinical and development activities for our investigational ARC-BCI System, leveraging grant funding, FDA Breakthrough Device Designation, and acceptance into the FDA’s new TAP program.

We also reaffirmed our recent guidance. Here are our unaudited Q4 2023 financial highlights:

✅ We plan to publish our Full Year 2023 financial statements on April 25, 2024. 
✅ The preliminary unaudited cash and cash equivalent balance on December 31, 2023, was EUR 29.8 million. 
✅ Net cash outflow in Q4, 2023 was EUR 7.0 million, consistent with the EUR 7.0M cash burn in Q3, 2023. 
✅ We confirm our previous guidance of expected cash runway through the end of 2024 and will look for efficient ways to strengthen its balance sheet in the coming months.

Read the press release: https://t.co/tx790p8toG

To learn more about ONWARD Medical’s commitment to partnering with the SCI Community to develop innovative solutions for restoring movement, function, and independence after spinal cord injury, please visit https://t.co/UDMerHIsOU. 

*All ONWARD Medical devices and therapies, including but not limited to ARC-IM®, ARC-EX®, ARC-BCI™, and ARC Therapy™, alone or in combination with a brain-computer interface (BCI), are investigational and not available for commercial use.

[ONWARD Medical @onwdempowered]

“Each and every day a person with paralysis wakes to a waiting wheelchair or powerchair, our legs for the time-being and an opportunity to start our day.” - @scottchesney, ONWARD Medical Brand Ambassador and paraplegic for 38 years

On this #InternationalWheelchairDay, we recognize those who use wheelchairs or powerchairs to move forward each day. While our mission to empower movement is directed at reducing the time one spends in a wheelchair or powerchair, we appreciate the importance and value of these devices, which have enhanced the quality of life of many since the sixth-century AD.

#EmpoweringMovement #SCI

[ONWARD Medical @onwdempowered]

The Brain-Computer Interface (BCI) system is a breakthrough technology enabling communication between the brain and the spinal cord, offering the potential for a person to regain movement in arms or legs after paralysis. This investigational system has already empowered individuals with spinal cord injuries (SCI) to improve their mobility as part of ongoing clinical studies.

ONWARD Medical, in collaboration with the other Reverse Paralysis Project members, invites you to share your insights to help us shape the development of this technology.

Survey Details:
• Target Audience: People with a spinal cord injury
• Duration: Approximately 10 minutes
• Link to Survey: https://t.co/6QNSWEejJQ

If you have any questions regarding this survey from @maartenskliniek or your participation, please email [email protected].

Your input is valuable to us. Thank you for your participation.

All ONWARD devices and therapies, including but not limited to ARC-IM®, ARC-EX®, and ARC Therapy™, alone or in combination with a brain-computer interface (BCI), are investigational and not available for commercial use.

#SpinalCordInjury #SCI #EmpoweringMovement #BCI #BrainComputerInterface #ReverseParalysisProject #Survey

[ONWARD Medical @onwdempowered]

We are deeply grateful for our partnership with the @ReeveFoundation. Our collaboration allows us to connect with the spinal cord injury (SCI) Community and understand their unmet needs.

This weekend, “Super/Man: The Christopher Reeve Story” will play at the @sundancefest. The documentary follows the journey of Christopher Reeve after he became paralyzed, a period during which @Variety notes “Reeve became a superhero again.” 🎥

Reeve’s story is an important one to share. His life’s work continues through the Christopher and Dana Reeve Foundation to help empower the SCI Community.

#EmpoweringMovement #SCI #ChristopherReeve

https://t.co/ATcXIqaSOk

[ONWARD Medical @onwdempowered]

38 years ago today, Scott Chesney became paralyzed. The events of that day changed the course of his life, and today he is a motivational speaker and ambassador to the SCI community. Recently, we had a conversation with Scott about the anniversary of his spinal cord injury (SCI). The thoughts he shared about how and why he marks his SCI anniversary were deeply moving. In our inaugural episode of ONWARD Journeys, Scott explains what his SCI anniversary means to him and the life lessons it’s delivered. We are always in awe of Scott’s honesty, depth, and willingness to get vulnerable to help others.
Watch here: https://t.co/7ION5Aq5h1

👉For those who are facing mental health challenges or are looking for someone who will listen, here are some resources:

♦️ National Crisis Hotline: [phone] (TALK)

♦️ Christopher & Dana Reeve Foundation Peer-to-Peer Support Groups: https://t.co/mUMOuLReB4

♦️ Model Systems Knowledge Translation Center information mental health fact sheets and self-assessment for signs of depression: https://t.co/22SRKXDo3Z

♦️ University of Washington pamphlets and self-test on depression: https://t.co/tVsrrW73OL

Learn about our commitment to partnering with the SCI community to develop innovative solutions for restoring movement, function, and independence after spinal cord injury at https://t.co/UDMerHIsOU.

#EmpoweringMovement #SCI

[ONWARD Medical @onwdempowered]

We are incredibly proud to partner with the Christopher & Dana Reeve Foundation. Recently, we had the pleasure of gathering with our friends at “Eve With Reeve,” an event to raise awareness and funds for spinal cord injury (SCI). The mission of the Reeve Foundation is to cure spinal cord injury by advancing innovative research and improving the quality of life for individuals and families impacted by paralysis. Our shared purpose brought us together in a strategic partnership in 2019, and our complementary areas of expertise make it exciting to learn from each other and collaborate.

Members of the ONWARD family came together in this memorable night. One of our biggest delights was spending time with Jessie, who took up painting as a hobby after participating in a clinical feasibility study at the University of Washington that evaluated the safety and effectiveness of our investigational ARC-EX platform to restore upper limb function after SCI. It was inspiring to watch her grasp the brush and make fine strokes on the canvas, resulting in a work of art that was beautiful and empowering. 🖌️🎨

The Reeve Foundation curated an evening that showcased how advocacy, innovation, and human connection make a visceral difference in the lives of people with SCI. Amid the profoundly critical work that’s taking place in the SCI Community, the memorable evening also highlighted the importance of reconnecting with collaborators and old friends amid music, dancing, and laughter – a good reminder of the power of joy.

Thank you, Christopher & Dana Reeve Foundation, for bringing the community together during this magical evening. 🌟

Photo credits: Genevieve Courtemanche and Freshly Cut Film

#EmpoweringMovement #SCI #EveWithReeve